Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/17/2010CA2476800C Crystals of glucopyranosyloxybenzyl benzene derivative
08/17/2010CA2473203C Orodispersible pharmaceutical composition comprising ivabradine
08/17/2010CA2473201C Orodispersible pharmaceutical composition comprising agomelatine
08/17/2010CA2472372C Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
08/17/2010CA2467065C Preparation for improving the action receptors to neurotransmitters and/or neuromodulators
08/17/2010CA2461963C Cyclic amine compounds
08/17/2010CA2461212C Diaryl sulfide derivatives, salts thereof and immunosuppressive agents using the same
08/17/2010CA2458544C Crystals of hydroxynorephedrine derivative
08/17/2010CA2456453C Cc-1065 analog synthesis
08/17/2010CA2455296C 5-halo-tryptamine derivatives used as ligands of the 5-ht6 and/or 5-ht7 serotonin receptors
08/17/2010CA2444980C Single dose aromatase inhibitor for treating infertility
08/17/2010CA2444867C Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent
08/17/2010CA2438991C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
08/17/2010CA2431974C Urea and urethane derivatives as integrin inhibitors
08/17/2010CA2427227C Lactam compound
08/17/2010CA2425497C (n)-((s)-2-hydroxy-3-methyl-butyryl-1-(l-alaninyl)-(s)-1-amino-3-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin-2-one dihydrate and its use in the treatment of alzheimer's disease
08/17/2010CA2412854C Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
08/17/2010CA2411436C A method for detecting protein inhibitors and ligands
08/17/2010CA2407208C Process for producing optically active sulfoxide derivative
08/17/2010CA2403086C Apoptosis inhibiting composition comprising a 15-keto-prostaglandin or derivative thereof
08/17/2010CA2397734C Water soluble prodrugs of azole compounds
08/17/2010CA2389036C Antisense modulation of integrin-linked kinase expression
08/17/2010CA2385269C Novel thiazolo(4,5-d)pyrimidine compounds
08/17/2010CA2384690C Rivastigmine for the treatment of ocular disorders
08/17/2010CA2383814C Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
08/17/2010CA2382940C 2-arylimino-2,3-dihydrothiazoles, and their use thereof as somatostatin receptor ligands
08/17/2010CA2378165C Dihydrobenzodiazepines and their use in the treatment of dyslipidaemia
08/17/2010CA2370412C Pharmaceutical compounds
08/17/2010CA2337828C Phosphinic and phosphonic acid derivatives used as pharmaceuticals
08/17/2010CA2325471C Piperididinyl and n-amidinopiperidinyl derivatives
08/17/2010CA2318008C Solid oral pharmaceutical formulation of modified release that contains an acid labile benzimidazole compound
08/17/2010CA2290742C Use of galt-2 inhibitor compounds to treat conditions associated with lactosylceramide
08/17/2010CA2259707C Disinfecting and sterilizing concentrate containing an aromatic dialdehyde and a neutral ph buffering system
08/17/2010CA2200695C Cationic transport reagents
08/17/2010CA2169260C Gene therapy for solid tumors, papillomas and warts
08/17/2010CA2124758C Trehalose-releasing enzyme, and its preparation and uses
08/12/2010WO2010091386A2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections
08/12/2010WO2010091382A1 Design, synthesis and evaluation of procaspase activating compounds as personalized anti-cancer drugs
08/12/2010WO2010091354A2 Akt tyrosine 176 phosphorylation cancer biomarker
08/12/2010WO2010091310A1 Inhibitors of jun n-terminal kinase
08/12/2010WO2010091308A2 Oligomeric compounds and methods
08/12/2010WO2010091306A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens
08/12/2010WO2010091303A1 Novel steroidal cyp17 inhibitors/antiandrogens
08/12/2010WO2010091301A1 Oligomeric compounds and excipients
08/12/2010WO2010091299A2 Novel combination cancer therapies
08/12/2010WO2010091280A1 N-halogenated amino acid formulations comprising phosphine or amine oxides
08/12/2010WO2010091277A2 Solid state forms of aliskiren compounds
08/12/2010WO2010091272A1 Methods and processes for syntheses and manufacture of antimicrobial 1-(ortho-fluorophenyl)dihydropyridones
08/12/2010WO2010091268A1 Pyrrolidine triple reuptake inhibitors
08/12/2010WO2010091257A1 Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
08/12/2010WO2010091226A1 Compositions and methods for organ preservation
08/12/2010WO2010091198A1 Therapeutic compositions comprising monoterpenes
08/12/2010WO2010091193A2 Triptolide c-ring derivatives as anticancer agents and immune modulators
08/12/2010WO2010091176A1 Phthalazine-containing antidiabetic compounds
08/12/2010WO2010091164A1 Inhibitors of glucosylceramide synthase
08/12/2010WO2010091150A1 Novel benzodiazepine derivatives
08/12/2010WO2010091140A1 Treatment of lung cancer with a parp inhibitor in combination with a growth factor inhibitor
08/12/2010WO2010091131A1 Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
08/12/2010WO2010091124A2 Bismuth-thiols as antiseptics for epithelial tissues, acute and chronic wounds, bacterial biofilms and other indications
08/12/2010WO2010091104A1 Glucosylceramide synthase inhibitors
08/12/2010WO2010091090A1 Cochleate compositions and methods of use
08/12/2010WO2010091052A2 Methods for enhancing hematopoietic stem/progenitor cell engraftment
08/12/2010WO2010091009A1 Isoxazole-3-carboxamide derivatives
08/12/2010WO2010090991A1 Formulations of desvenlafaxine
08/12/2010WO2010090969A1 Tetrahydropyran nucleic acid analogs
08/12/2010WO2010090875A1 Derivatives of n2-(3-pyridil or phenyl)-n4-(4-piperidyl)-2,4-pyrimidinediamine useful in the treatment of inflammatory, autoimmune or proliferative diseases
08/12/2010WO2010090860A2 Methods and compositions for treating bacterial infection
08/12/2010WO2010090830A1 Modulation of sirt1 expression
08/12/2010WO2010090765A2 Intrathecal baclofen pharmaceutical dosage forms with fewer degradation products
08/12/2010WO2010090764A1 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010WO2010090762A1 Rna duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
08/12/2010WO2010090744A1 Methods and compositions for treating neuropathies
08/12/2010WO2010090737A1 Pyridazinone compounds
08/12/2010WO2010090723A2 Methods of inhibiting fibrogenesis and treating fibrotic disease
08/12/2010WO2010090716A1 Heteroaryls and their use as pi3k inhibitors
08/12/2010WO2010090680A1 Substituted oxindole cb2 agonists
08/12/2010WO2010090654A1 Methods of reducing the proliferation and viability of microbial agents
08/12/2010WO2010090614A1 Pharmaceutical formulation comprising risedronate, calcium carbonate and vitamin d3 combined in a single dosage form
08/12/2010WO2010090613A1 The combined pharmaceutical composition in a single dosage form
08/12/2010WO2010090612A1 Stable, taste and odor masked pharmaceutical compositions comprising acetylcystein and vitamin c
08/12/2010WO2010090546A1 Composition of amino acids for sublingual applying for enhanced skin integument repigmentation in vitiligo and method of its administration
08/12/2010WO2010090532A1 Compositions and dosage regimes comprising a clostridial vaccine and levamisole
08/12/2010WO2010090502A2 External use composition containing cholecalciferol or its derivative for treating skin disorders
08/12/2010WO2010090498A2 Pharmaceutical composition and health food composition containing youngia denticulata extract, fraction thereof, or compound isolated therefrom as active ingredient for improving liver function
08/12/2010WO2010090494A2 Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof
08/12/2010WO2010090347A1 Dihydroquinolinone derivatives
08/12/2010WO2010090305A1 Substituted acylguanidine derivative
08/12/2010WO2010090304A1 Acylguanidine derivative
08/12/2010WO2010090300A1 Diazepinedione derivatives
08/12/2010WO2010090299A1 A novel cyanopyrimidine derivative
08/12/2010WO2010090290A1 Aminopyrazine derivative and medicine
08/12/2010WO2010090236A1 Hesperidin-containing composition
08/12/2010WO2010090234A1 12-deoxyfusicoccin sugar chain-modified derivatives and uses thereof
08/12/2010WO2010090200A1 Phenylimidazole compounds
08/12/2010WO2010090172A1 Pharmaceutical composition for oral administration
08/12/2010WO2010090009A1 Indoline derivatives
08/12/2010WO2010089874A1 Ppar-γ-expression-enhancing agent, adiponectin-production-enhancing agent, ucp-activating agent, and pharmaceutical preparation, food or beverage comprising any one of the agents
08/12/2010WO2010089768A2 Pharmaceutical composition
08/12/2010WO2010089752A1 Carjbamoylphosphonates as inhibitors and uses thereof
08/12/2010WO2010089729A1 Processes for the preparation of cefozopran, its salts and polymorphic forms thereof
1 ... 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 ... 7860